We are testing a new medication called GTX-11 to see how safe it is and how the body handles it. Healthy adults are participating to help us understand its effects.
Health conditions and diseases that the clinical trial is designed to study and treat.
Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred, leading to difficulty in breathing and reduced oxygen supply to the body. It can be idiopathic, meaning the cause is unknown, or related to other conditions.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.